Regulations and Regulatory Issues

The U.S. Secretary of Agriculture, Sonny Perdue, announced the establishment of the U.S. Domestic Hemp Production Program on October 29, 2019.  

A number of causes of hemp testing insanity are documented such as different states using different THC measures to determine legality, lack of representative sampling, and more.

A review of the expert strategies and resources to streamline the laboratory accreditation process.

An explanation on the theory and measurement of water activity, its mode of action for microbial control, existing water activity regulations for cannabis, and more.

What changes need to be adopted in our industry to make the transition to the pharmaceutical industry testing paradigm?

Enterprise resource planning (ERP) helps provide control and visibility to critical cannabis business management issues, such as data, inventory, quality, and traceability. The author explains how it works.

Three former and current state regulators discuss their collaborative work in the cannabis industry.

Where does cannabidiol’s (CBD) legal status stand following the 2018 Farm Bill? One attorney looks at common misperceptions.

An outline of some of the current major challenges for both regulators and laboratories regarding the microbial testing of cannabis products.

This article is intended to spark conversations about measurement uncertainty that lead to the recognition and application of effective uncertainty budgets in the cannabis arena.

George Anastassov, the CEO of AXIM Biotech, recently spoke to us about the current good manufacturing methods (cGMPs) his company has developed, their significance to the market, and plans for the future.

The agencies sent warning letters to several companies that the agencies say are illegally marketing unapproved products to treat opioid addiction and withdrawal.